Aemetis (AMTX) Stock Forecast & Price Target

Aemetis is viewed favorably because its Q2 fiscal 2026 revenue rose to $63 million from $52 million year over year, while EPS of $(0.16) beat both estimates and the company posted much better gross margins, operating income, and EBITDA. The outlook is further supported by progress across its four main initiatives, including a biogas network expanded to 15 dairies with 40 miles of pipeline, more than 50 dairy agreements signed, and India revenue expected to rebound with new contracts in 2026 and an IPO soon. Regulatory and policy catalysts such as year-round E15 expansion, CARB approval for dairy digester RNG pathways, and Section 45Z credits extended to 2029 could materially improve economics, positioning the business near an inflection point despite tight liquidity and past losses.

Aemetis is facing a weak fundamental backdrop, as repeated losses of $11 million and $22 million show that profitability remains elusive despite management’s ambitious revenue roadmap. The company’s financial position is strained, with only about $1 million to $5 million in cash against $533 million to $546 million in debt, leaving little cushion for execution risk or adverse operating conditions. Its outlook is further pressured by delayed revenue milestones, balance sheet and liquidity concerns, and exposure to political, regulatory, commodity, and demand volatility across its North America and India operations.